TabletsTablets
Schedule H1 (Prescription Required - Habit Forming Warning)Anxiolytics & SedativesCode: 1281

Chlordiazepoxide Tablets 10 mg

Generic Formulation:Chlordiazepoxide Tablets IP 10 mg
Pack Size:10's
Common Commercial Brand Equivalents:Market reference only
Jan Aushadhi MRP
₹19.69
Brand Estimate*
₹40.24
Estimated Savings:₹20.55 (51% saved)
Find a Kendra Near You
*Statutory price across 21,118 listed Kendras
Clinical InformationReport Error

Clinical Overview

Chlordiazepoxide is the historical first-discovered benzodiazepine. It acts by binding to stereospecific GABAA receptors in the central nervous system, enhancing chloride ion channel opening and augmenting GABA-mediated neuronal inhibition. Possesses active metabolites with a long elimination half-life. Indicated for short-term relief of severe anxiety disorders and acute management of alcohol withdrawal symptoms.

Active Pharmaceutical Ingredients

AI-assistedClinical summary synthesized from pharmacopoeial references (CDSCO, WHO EML, IP/BP/USP). Not clinician-reviewed. Drug code 1281.Report inaccuracy

Usage Guidelines

Take orally with a glass of water, with or without food. Follow exact prescribed dosing. Do not discontinue suddenly after prolonged therapy.

General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.

Possible Side Effects

Common: Drowsiness, ataxia, confusion, constipation, dizziness, syncope in the elderly. Rare/Severe: Dependence, withdrawal delirium/seizures, respiratory depression, and blood dyscrasias.

*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.

Precautions & Warnings

Black box warnings for abuse, misuse, addiction, and concurrent opioid fatality risks. Contraindicated in severe hepatic impairment and myasthenia gravis. Avoid alcohol.

Schedule H1 (Prescription Required - Habit Forming Warning)

This medication is scheduled under statutory drug regulatory frameworks (CDSCO / Drugs & Cosmetics Rules). Dispensing requires a valid medical prescription from a registered medical practitioner. Self-medication or unsupervised dosage adjustment carries significant clinical risks.

Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, clinical diagnosis, or treatment recommendations. Always consult a registered medical practitioner or qualified pharmacist before initiating, modifying, or substituting any medication regimen.